GHK-Cu — glycyl-L-histidyl-L-lysine bound to copper — is a tripeptide your body makes naturally; it is found in plasma, saliva, and urine. It signals fibroblasts to produce collagen and elastin, accelerates wound and tissue remodeling, and shifts gene expression toward repair. Levels fall about 60% between age 20 and 60, which is a big part of why skin thins and heals slower over time.
In a controlled human trial, GHK-Cu applied to skin raised collagen in 70% of volunteers — beating vitamin C (50%) and retinoic acid (40%) — and improved firmness and elasticity. At the gene level it modulates over 4,000 human genes, including 47 directly involved in DNA repair. PeRx delivers it as a subcutaneous injection, which reaches skin, connective tissue, and hair follicles at a full therapeutic dose — not just the surface layers a topical serum can touch.
PeRx ships GHK-Cu fully reconstituted from an FDA-registered 503A pharmacy. No mixing — insulin syringes and a step-by-step guide arrive in the box. It is a subcutaneous injection on a provider-determined schedule.